These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5653338)

  • 1. [The clinical use of the nicotinic ester of diethylaminoethanol (Euclidan) in cerebral vascular diseases].
    Alloro L; Terenziani S
    Minerva Med; 1968 May; 59(42):2466-73. PubMed ID: 5653338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
    Cosmi F; Caresia L; Panebianco G
    Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of cerebral vascular insufficiency].
    Hirsch W; Woschée G
    Ther Ggw; 1967 Sep; 106(9):1186-7 passim. PubMed ID: 5623071
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the therapy of cerebral and peripheral circulatory disorders].
    Klein L
    Med Welt; 1969 Aug; 35():1913-6. PubMed ID: 4390197
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
    Szobor A; Klein M; Bräuer H
    MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cerebral vasculopathies with a new pharmacologic combination].
    Gazzi A
    Policlinico Med; 1966 Feb; 73(1):39-47. PubMed ID: 5941604
    [No Abstract]   [Full Text] [Related]  

  • 8. Cosaldon for vascular disorders?
    Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical efficacy of nicergoline in cerebrovascular diseases. Statistical study].
    Guardamagna C; Negri S
    Minerva Cardioangiol; 1972 Nov; 20(11):636-41. PubMed ID: 4566130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged therapy of insufficient cerebral circulation].
    Jansen W
    Med Monatsschr; 1970 Oct; 24(10):471-2. PubMed ID: 4394418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Report on experiences with the complex treatment of cerebral and peripheral circulatory disorders].
    Basarab A
    Med Welt; 1973 Apr; 24(16):650-2. PubMed ID: 4756330
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effects of sodium nicotinate and dihydroergotamine on cerebral circulation. Rheographic studies in subjects with cerebral vascular diseases].
    Arrigo F; Turiano S; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):292-7. PubMed ID: 4786565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with a compound preparation in the treatment of cerebral blood circulation disorders in practice].
    Bremer C
    Z Allgemeinmed; 1970 Mar; 46(9):478-9. PubMed ID: 4399649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study].
    Koeppen G; Schmidt-Modrow G
    Ther Ggw; 1979 Nov; 118(11):1704-13. PubMed ID: 538738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ambulatory treatment of cerebrovascular disorders including encephalographic and ophthalmologic studies].
    Leube H; Schwaeppe C
    Med Monatsschr; 1970 Aug; 24(8):366-9. PubMed ID: 5515138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of cerebrovascular and cardiac insufficiency].
    Kief W; Schmidt-Modrow G
    Med Welt; 1977 Oct; 28(42):1730-2. PubMed ID: 337039
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cerebral circulation disorders].
    Brinkmann G; Guthy H; Hildgen J
    Dtsch Med J; 1969 Dec; 20(24):247-9. PubMed ID: 4394415
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new product acting on cerebral circulation: results of the use in neurosurgery of 7-(2 hydroxy-3-N-2-hydroxy-ethyl-N-methylamino propyl) 1-3 dimethylaxanthine pyridine-3-carboxyl or complamin].
    Pouyanne H; Guérin J; Maurin P
    J Med Bord; 1967 Nov; 114(11):1693-702. PubMed ID: 5602594
    [No Abstract]   [Full Text] [Related]  

  • 20. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.